Prevalence and Risk Factors of Atypical Femoral Fracture Bone Scintigraphic Feature in Patients Experiencing Bisphosphonate-Related Osteonecrosis of the Jaw-Reference-Cited by-同舟云学术

Prevalence and Risk Factors of Atypical Femoral Fracture Bone Scintigraphic Feature in Patients Experiencing Bisphosphonate-Related Osteonecrosis of the Jaw

Published:2018-07-16 Issue:4 Volume:52 Page:311-317
ISSN:1869-3474
Container-title:Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Nucl Med Mol Imaging

Author:

Lee Chang-Hee,Son Seung Hyun,Hong Chae Moon,Jeong Ju Hye,Jeong Shin Young,Lee Sang-Woo,Lee Jaetae,Kwon Tae-Geon,Ahn Byeong-Cheol^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s13139-018-0533-x/fulltext.html

Reference31 articles.

1. Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA. 2006;296:2927–38.

2. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–22.

3. Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241–9.

4. Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, et al. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy randomised controlled trial. Lancet. 2009;373:1253–63.

5. Devogelaer JP. Modern therapy for Paget's disease of bone: focus on bisphosphonates. Treat Endocrinol. 2002;1:241–57.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are secondary effects of bisphosphonates on the vascular system of bone contributing to increased risk for atypical femoral fractures in osteoporosis?;BioEssays;2023-02-20

2. A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities;Supportive Care in Cancer;2021-09-27

3. Non-Viral Delivery System and Targeted Bone Disease Therapy;International Journal of Molecular Sciences;2019-01-29